XTX Topco Ltd Takes Position in DocuSign, Inc. (NASDAQ:DOCU)

XTX Topco Ltd bought a new position in DocuSign, Inc. (NASDAQ:DOCU) in the second quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 37,859 shares of the company’s stock, valued at approximately $2,025,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Optimist Retirement Group LLC increased its holdings in DocuSign by 5.6% in the 2nd quarter. Optimist Retirement Group LLC now owns 4,255 shares of the company’s stock worth $228,000 after buying an additional 227 shares during the period. Elo Mutual Pension Insurance Co boosted its holdings in shares of DocuSign by 1.1% in the 2nd quarter. Elo Mutual Pension Insurance Co now owns 18,848 shares of the company’s stock valued at $1,008,000 after acquiring an additional 214 shares during the last quarter. Blair William & Co. IL increased its stake in shares of DocuSign by 23.1% in the second quarter. Blair William & Co. IL now owns 469,068 shares of the company’s stock worth $25,095,000 after acquiring an additional 87,965 shares during the period. Vanguard Personalized Indexing Management LLC raised its holdings in shares of DocuSign by 2.9% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 10,080 shares of the company’s stock worth $539,000 after purchasing an additional 286 shares during the last quarter. Finally, Primecap Management Co. CA raised its holdings in shares of DocuSign by 22.4% during the second quarter. Primecap Management Co. CA now owns 452,450 shares of the company’s stock worth $24,206,000 after purchasing an additional 82,700 shares during the last quarter. Institutional investors and hedge funds own 77.64% of the company’s stock.

Insiders Place Their Bets

In other news, Director Daniel D. Springer sold 287,052 shares of the firm’s stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $53.78, for a total value of $15,437,656.56. Following the transaction, the director now owns 923,445 shares in the company, valued at $49,662,872.10. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, Director Daniel D. Springer sold 287,052 shares of the business’s stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $53.78, for a total transaction of $15,437,656.56. Following the completion of the sale, the director now directly owns 923,445 shares in the company, valued at $49,662,872.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Daniel D. Springer sold 70,983 shares of the firm’s stock in a transaction on Monday, August 5th. The shares were sold at an average price of $49.84, for a total value of $3,537,792.72. Following the completion of the transaction, the director now owns 891,373 shares in the company, valued at approximately $44,426,030.32. The disclosure for this sale can be found here. In the last three months, insiders sold 460,864 shares of company stock worth $24,549,227. Corporate insiders own 1.66% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have commented on DOCU. Wells Fargo & Company upped their price target on shares of DocuSign from $48.00 to $50.00 and gave the company an “underweight” rating in a report on Friday, September 6th. Piper Sandler lowered their target price on DocuSign from $65.00 to $60.00 and set a “neutral” rating on the stock in a research note on Friday, June 7th. Bank of America lifted their price target on DocuSign from $60.00 to $68.00 and gave the company a “neutral” rating in a research report on Friday, September 6th. Royal Bank of Canada upped their price objective on DocuSign from $52.00 to $57.00 and gave the stock a “sector perform” rating in a research report on Friday, September 6th. Finally, Morgan Stanley dropped their price objective on shares of DocuSign from $65.00 to $62.00 and set an “equal weight” rating on the stock in a research note on Friday, June 7th. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $61.45.

DocuSign Price Performance

Shares of DOCU stock opened at $57.91 on Friday. DocuSign, Inc. has a 1-year low of $38.11 and a 1-year high of $64.76. The company has a market cap of $11.86 billion, a price-to-earnings ratio of 111.37, a PEG ratio of 5.99 and a beta of 0.93. The stock has a 50 day simple moving average of $55.84 and a 200-day simple moving average of $56.14.

DocuSign (NASDAQ:DOCU) last posted its quarterly earnings data on Thursday, September 5th. The company reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.17. The business had revenue of $736.03 million for the quarter, compared to the consensus estimate of $727.20 million. DocuSign had a net margin of 34.56% and a return on equity of 16.18%. The company’s revenue was up 7.0% compared to the same quarter last year. During the same period last year, the firm posted $0.09 earnings per share. Analysts anticipate that DocuSign, Inc. will post 0.99 earnings per share for the current fiscal year.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.